Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,40826,102,1.69 [1.27-2.26],0.0003835415771779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,40826,102,1.30 [1.02-1.66],0.0311007575185188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,41331,103,1.38 [1.03-1.85],0.0327733737443164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,40651,102,2.56 [1.36-4.83],0.0036630897037186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,34555,92,1.46 [1.05-2.03],0.0230432650334352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,40780,102,1.71 [1.17-2.50],0.005613550923776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34646,90,1.67 [1.07-2.61],0.023845748683831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40294,103,3.17 [1.83-5.49],4.013913708502907e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40720,102,1.88 [1.16-3.07],0.0110738920068359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41312,103,2.90 [2.26-3.73],1.0498992263979856e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35523,94,2.89 [1.75-4.79],3.481334765060595e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,35523,94,1.91 [1.39-2.62],6.566350510625321e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,41181,102,4.49 [2.73-7.39],3.1093218876591683e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,41323,105,3.12 [2.39-4.05],2.6157649873248924e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,40590,101,1.53 [1.19-1.98],0.0010349486801817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,35700,95,0.58 [0.37-0.90],0.0149231280738041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,34729,89,3.73 [2.70-5.17],1.7711089449509057e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,35700,95,2.11 [1.06-4.20],0.0328321314343254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,34914,93,2.27 [1.33-3.86],0.0026691928059931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,40294,103,0.65 [0.43-0.99],0.0454072832559354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,41521,106,11.76 [5.50-25.16],2.1474793345032568e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35624,95,1.64 [1.17-2.31],0.0045662036056804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,40284,100,1.54 [1.08-2.18],0.0156801884978735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,35608,95,1.43 [1.10-1.86],0.0071678185862638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,40863,102,0.79 [0.65-0.97],0.0240612854176023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,34729,89,0.40 [0.19-0.86],0.0193761723578699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,34213,87,1.81 [1.53-2.13],4.47008056270812e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],40284,100,0.63 [0.41-0.96],0.0323810330149827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40826,102,1.88 [1.46-2.40],7.219129286202282e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41269,103,2.78 [2.31-3.35],6.435226129797013e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,41111,103,0.44 [0.24-0.79],0.0058372132225609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,40969,103,0.71 [0.54-0.93],0.012594387381987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,40658,100,1.79 [1.20-2.67],0.004274147716717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,40821,101,1.41 [1.01-1.96],0.0449732043306751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,40089,100,1.78 [1.46-2.17],1.215775043083566e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,40064,101,1.89 [1.57-2.28],2.303485343378157e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,35674,93,0.45 [0.21-0.98],0.0441234722822126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,35523,94,1.76 [1.33-2.34],8.353336941946397e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,41170,103,1.86 [1.00-3.45],0.0481867570745719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,35624,95,1.55 [1.13-2.12],0.0064309596629249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,35728,94,1.63 [1.25-2.12],0.0002964310541442
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",41181,102,9.82 [6.29-15.35],1.0361206945558857e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,34646,90,1.87 [1.39-2.51],3.460713185325802e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,40294,103,1.59 [1.00-2.53],0.0486798100139239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,35608,95,1.86 [1.66-2.10],4.51693299687156e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,41027,103,2.04 [1.04-4.02],0.0393012223278876
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,35523,94,2.35 [2.05-2.70],5.957424009963496e-35
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,35680,94,0.68 [0.55-0.85],0.000571014680933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,34729,89,1.38 [1.01-1.90],0.0449860886522589
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,40024,100,1.21 [1.05-1.40],0.0094442567538019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,34646,90,2.66 [2.27-3.12],3.0916769753716205e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,41027,103,1.27 [1.00-1.62],0.0492507997834599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,34914,93,2.25 [1.05-4.80],0.0364817613539239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,34646,90,2.89 [2.19-3.80],3.826419514348986e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,40933,102,0.76 [0.58-0.99],0.0431328655241995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,34584,91,1.57 [1.06-2.33],0.0255000627538019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSG,Basigin,41415,104,3.80 [1.70-8.50],0.0011744140410546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,41382,103,1.46 [1.10-1.94],0.0079516725234081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,40089,100,0.72 [0.55-0.94],0.0142696438559938
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,41181,102,3.62 [2.11-6.23],3.270549546081949e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,40974,103,1.87 [1.27-2.75],0.001485063539558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,41280,104,3.34 [1.69-6.60],0.000541962762694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35624,95,1.64 [1.03-2.62],0.0359493262078738
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,35661,94,4.61 [1.65-12.86],0.0035327656236897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2,Complement C2,41111,103,0.57 [0.40-0.83],0.0029997174634973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,34874,94,1.95 [1.05-3.63],0.0340741453648339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,35608,95,3.21 [2.67-3.85],9.098076453998217e-36
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,35700,95,1.50 [1.03-2.17],0.0333744275477211
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,35523,94,1.30 [1.03-1.64],0.0255952370747366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,34729,89,1.41 [1.09-1.81],0.0090551212655401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,40891,104,15.02 [6.72-33.61],4.186316975696203e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,40751,100,1.68 [1.30-2.17],7.648372965197758e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,35020,92,0.79 [0.67-0.92],0.0025474070332483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,34555,92,0.35 [0.18-0.67],0.0013490070731914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,40966,104,0.80 [0.65-0.98],0.031628130256582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,35608,95,1.39 [1.13-1.72],0.002013665653411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,35624,95,1.60 [1.38-1.84],1.3889171870338618e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,41488,104,0.64 [0.41-0.99],0.0432475507329954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,41421,104,0.76 [0.59-0.98],0.0353814157625269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,40928,102,0.78 [0.64-0.94],0.0113592195746712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,40974,103,0.80 [0.65-0.99],0.04288363162861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,40974,103,1.56 [1.38-1.77],1.416194859259647e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,41055,102,1.35 [1.13-1.62],0.0009771133415698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,41170,103,0.74 [0.63-0.88],0.0006493974055888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,40760,102,0.70 [0.56-0.88],0.002179427166302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,40993,100,0.52 [0.38-0.72],7.972017212624929e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,35020,92,2.44 [1.39-4.29],0.0019307963659352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,40182,101,1.68 [1.13-2.51],0.0107408340736827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,41170,103,2.00 [1.38-2.89],0.0002471552859734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,40966,103,1.40 [1.19-1.64],3.224862126949349e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,41133,105,4.13 [2.02-8.45],0.0001049752992691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,40974,103,6.38 [5.30-7.69],1.1689164064449995e-84
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,41488,104,5.75 [4.84-6.83],1.663908868920165e-88
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,34646,90,0.58 [0.35-0.95],0.0306330202185108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,41133,105,6.65 [5.18-8.54],9.199271675119507e-50
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,40720,102,1.73 [1.09-2.73],0.0189836935013362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,40089,100,2.39 [1.91-3.00],2.820766783203985e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,41020,104,1.32 [1.02-1.72],0.0361980646959824
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,34914,93,2.83 [1.55-5.16],0.0006840669383051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,41382,103,1.92 [1.19-3.08],0.0070438607319425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,41259,102,1.79 [1.20-2.65],0.0040978581676977
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,41393,103,1.59 [1.14-2.20],0.0056674465520313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,40826,102,1.73 [1.01-2.96],0.0459706792399635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,41240,103,2.14 [1.06-4.32],0.0349301642713184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,41488,104,0.76 [0.61-0.94],0.0115646458421927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,40776,102,2.98 [1.97-4.51],2.254425944937464e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,41121,102,19.51 [13.88-27.42],1.207744631130887e-65
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,41334,103,6.12 [5.28-7.11],1.7885985121335347e-125
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,39542,98,2.90 [1.62-5.19],0.0003284682345441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,35541,92,0.54 [0.35-0.83],0.0048731156850026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,41415,104,4.93 [3.67-6.62],3.623987692803068e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,40651,102,0.63 [0.45-0.89],0.0084309721878479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,34580,90,1.71 [1.17-2.51],0.0058654070372385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,40974,103,5.91 [4.89-7.15],5.698706735458608e-75
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,34914,93,8.18 [6.54-10.24],4.2881096614627723e-75
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,41382,103,9.38 [6.89-12.76],5.29567611968461e-46
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,41488,104,6.65 [5.62-7.86],9.89298699537768e-109
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,35674,93,8.64 [6.53-11.42],9.877414647228816e-52
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,40974,103,6.60 [4.51-9.66],2.775900055367103e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,35523,94,4.81 [2.95-7.87],3.4824693655618637e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,41382,103,1.74 [1.29-2.34],0.0002534326423455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,40089,100,1.47 [1.14-1.88],0.0027947454977342
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,40720,102,1.58 [1.18-2.11],0.0018520024761643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,41306,103,0.64 [0.47-0.88],0.0059634429262722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,41020,104,0.68 [0.52-0.90],0.0069023620976748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,41382,103,2.78 [1.88-4.09],2.499734655209907e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,34427,89,1.91 [1.13-3.22],0.0159761864339141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41054,102,0.49 [0.26-0.92],0.0253655691630243
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40974,103,1.35 [1.11-1.62],0.0020028381970777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35680,94,0.51 [0.30-0.88],0.0160493405373266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,34646,90,1.56 [1.03-2.37],0.0357211895858621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,34555,92,0.43 [0.22-0.87],0.0187801705472669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,39978,103,1.34 [1.05-1.71],0.0182543635673101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,40089,100,1.38 [1.08-1.77],0.0097072078817318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,40826,102,0.72 [0.54-0.96],0.0234929434895921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,34914,93,0.52 [0.35-0.76],0.000797159978899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35608,95,2.75 [2.20-3.44],1.0840890034839605e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,35512,93,1.93 [1.22-3.07],0.0053644791792184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,34720,90,1.60 [1.15-2.23],0.0051114263414458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,41289,104,2.42 [1.77-3.31],3.637799635408008e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,35680,94,1.51 [1.08-2.11],0.0156229190437989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,40956,104,0.69 [0.52-0.92],0.0116465681337392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,40951,103,0.70 [0.49-0.99],0.0465062664138176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,34646,90,4.04 [2.80-5.84],9.706738267344397e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,40294,103,1.95 [1.19-3.19],0.008247991274881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,40974,103,2.39 [1.74-3.28],6.25339083722569e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,35608,95,3.81 [2.79-5.20],3.134923811255488e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,41521,106,2.04 [1.08-3.85],0.0288366397169252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,40974,103,2.02 [1.40-2.91],0.0001621230242434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,35674,93,3.17 [2.29-4.40],3.955849369786362e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,41188,104,2.36 [1.14-4.90],0.0207054758837005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,34729,89,0.75 [0.57-0.98],0.036433814984151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,41020,104,2.10 [1.42-3.12],0.0002290038269396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,35020,92,1.64 [1.30-2.07],3.2927353405703334e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,40982,102,2.02 [1.07-3.83],0.0299131200845893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,40064,101,0.59 [0.36-0.96],0.0342093795152167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,41330,103,1.84 [1.18-2.88],0.0075373230879434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,41133,105,0.70 [0.54-0.91],0.006717970270434
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,35561,93,3.41 [2.06-5.64],1.6821380317744506e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,41170,103,2.71 [1.93-3.81],7.942774399551565e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,40021,99,1.99 [1.66-2.38],1.3829673093203206e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,41181,102,3.59 [1.63-7.95],0.0015762731702054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,35366,95,0.47 [0.23-0.96],0.0382289620856578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,41181,102,5.40 [2.73-10.67],1.229116596148077e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,40720,102,4.31 [3.21-5.77],1.6690571313703097e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,41181,102,5.06 [2.95-8.68],3.6013495679576366e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,35700,95,2.54 [1.88-3.44],1.2307985632469955e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,34646,90,1.84 [1.14-2.96],0.01195141402956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,35624,95,1.57 [1.03-2.38],0.0359829203013921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,40457,103,2.10 [1.51-2.94],1.1845630809370624e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,40294,103,0.80 [0.64-0.99],0.0390186450231075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,41044,104,1.67 [1.24-2.25],0.0007009570430722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,40168,101,1.30 [1.03-1.65],0.0266590172383524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,41020,104,5.33 [2.98-9.53],1.6811258480917594e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,32291,88,3.86 [1.76-8.46],0.0007372961009396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,41264,102,0.49 [0.31-0.77],0.0019513397282146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,41033,103,1.88 [1.10-3.21],0.0218294437167496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,34720,90,1.51 [1.08-2.11],0.0172583598064531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,35313,93,1.98 [1.70-2.31],1.6796911417020815e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,41382,103,1.51 [1.30-1.75],7.95907422784923e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,40995,102,0.70 [0.59-0.83],4.700433983323927e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,40885,104,0.74 [0.64-0.86],0.0001048425889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,41181,102,1.44 [1.16-1.80],0.0010657296611276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,35116,93,2.89 [2.34-3.57],6.341046722932957e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,40840,102,1.28 [1.03-1.60],0.0267058741800744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,41020,104,4.78 [3.10-7.38],1.5124736187905569e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,34555,92,1.63 [1.16-2.30],0.0051265481760337
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,41382,103,5.99 [3.48-10.30],9.961821070273348e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,35680,94,1.71 [1.15-2.54],0.0077146521733152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,34646,90,2.07 [1.29-3.32],0.0026787515583496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,40089,100,1.48 [1.20-1.84],0.0003280467715603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,40197,102,0.68 [0.47-0.99],0.043227591331475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,41488,104,1.54 [1.22-1.95],0.0003432859119258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,34584,91,1.91 [1.61-2.27],1.42163303870296e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,35512,93,2.05 [1.67-2.53],1.2468412202574258e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,41382,103,0.67 [0.50-0.89],0.0065957357337999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,40826,102,1.47 [1.15-1.89],0.0022325278408936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,41133,105,2.70 [1.59-4.57],0.0002214442037079
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,34729,89,0.41 [0.24-0.69],0.0009335322568941
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,34729,89,1.56 [1.17-2.08],0.0023359799099679
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,35523,94,1.39 [1.09-1.79],0.0092232829086194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,35523,94,0.81 [0.69-0.96],0.0147324480689012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,40720,102,1.99 [1.60-2.47],5.690441419583153e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,40826,102,4.08 [2.57-6.48],2.6653513955285194e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,41269,103,1.76 [1.43-2.16],6.937783302478147e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,40552,102,1.95 [1.21-3.12],0.005856817148771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,35624,95,3.90 [2.40-6.36],4.550092933522703e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,35446,93,1.72 [1.18-2.51],0.0044459171205995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,40826,102,6.40 [4.36-9.41],3.3920152954594914e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,35608,95,1.97 [1.34-2.90],0.0006074405862722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,34720,90,1.30 [1.04-1.62],0.019342633422992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,41331,103,3.25 [2.03-5.19],8.604083473341687e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,41393,103,1.82 [1.18-2.81],0.0068868525002703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,40974,103,0.76 [0.63-0.93],0.0074471091007843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,34555,92,0.31 [0.15-0.66],0.0024395385817045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,34729,89,1.98 [1.01-3.89],0.0467454355225673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,35523,94,1.71 [1.10-2.66],0.0180698021959886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,35624,95,1.60 [1.03-2.47],0.035765710740057
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,40961,102,2.67 [1.57-4.54],0.0002797458553919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,40651,102,9.65 [7.44-12.53],4.529536381212732e-65
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,40931,101,0.84 [0.71-0.99],0.0388826161487575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,40089,100,0.46 [0.29-0.75],0.001877974299866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,40974,103,1.82 [1.60-2.06],5.35441168213612e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,34729,89,0.84 [0.71-1.00],0.0437396461778149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,40826,102,2.22 [2.00-2.47],1.3656836399163636e-48
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,41521,106,6.45 [2.91-14.33],4.648250806140604e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,34555,92,3.14 [2.25-4.39],1.6458103277204257e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41521,106,2.86 [1.57-5.20],0.0005841649819887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40294,103,3.96 [1.90-8.24],0.0002332857577214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,34729,89,2.06 [1.65-2.58],2.8093682395759644e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,40981,102,0.82 [0.68-0.99],0.0380793553906177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,39571,100,2.95 [2.06-4.23],3.805532709837025e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,34914,93,5.25 [2.72-10.13],7.883504790222351e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,41521,106,2.75 [1.49-5.08],0.0012086591979239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,40644,102,4.51 [2.79-7.29],7.18451895583441e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,40974,103,1.44 [1.21-1.71],3.4966796747706246e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41331,103,5.34 [3.80-7.50],5.628960155898647e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,40644,102,0.65 [0.50-0.83],0.0006481584608928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,35020,92,3.21 [2.47-4.16],1.9576492352841296e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,41382,103,10.92 [8.23-14.49],1.3250571903018776e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,40966,104,2.52 [1.47-4.34],0.0008285713072436
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,41393,106,1.60 [1.17-2.20],0.0036235992412256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,35680,94,2.03 [1.10-3.73],0.0227232488708256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35674,93,2.15 [1.69-2.74],3.6551044887916143e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35624,95,2.34 [1.24-4.42],0.0086529880950736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,41027,103,4.46 [4.04-4.92],1.2262589167271424e-194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,40089,100,1.71 [1.39-2.10],4.788239739198654e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,41020,104,22.71 [10.98-46.98],3.69248866660999e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,41297,104,3.18 [2.80-3.60],6.855920158279601e-72
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,40284,100,5.70 [4.95-6.56],1.788824968355558e-129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,41027,103,5.52 [4.39-6.93],6.7547993428323024e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,40089,100,1.62 [1.36-1.94],7.510758641616217e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,40089,100,1.54 [1.36-1.75],1.379989936847704e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,40974,103,1.85 [1.48-2.30],3.891386064570125e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,41331,103,1.41 [1.10-1.81],0.0065393043746669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,34646,90,0.44 [0.22-0.89],0.0230817096179641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,34427,89,0.59 [0.40-0.87],0.0078857869313675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,41133,105,2.13 [1.02-4.47],0.0446807614422923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40720,102,1.51 [1.00-2.28],0.0475743227126695
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40720,102,1.88 [1.05-3.38],0.0346061447372322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,40089,100,1.63 [1.07-2.49],0.022822252188855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,41488,104,1.90 [1.15-3.13],0.0117610110525827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,40064,101,1.29 [1.07-1.56],0.0066013646011559
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,34646,90,1.94 [1.45-2.59],7.352357754731304e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,40974,103,1.50 [1.23-1.82],5.2519082843777794e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,40589,102,2.19 [1.04-4.59],0.0385986267677729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,34729,89,2.28 [1.00-5.20],0.0496011676271969
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,40919,102,1.88 [1.12-3.15],0.0170574014526957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,34914,93,1.38 [1.03-1.86],0.0326131572802716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FURIN,Furin,41133,105,0.57 [0.34-0.96],0.0357449043307271
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,40028,100,3.72 [3.01-4.60],4.1026992763803605e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41382,103,1.76 [1.23-2.53],0.0022191649059976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,41181,102,0.68 [0.52-0.89],0.005780354956712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40284,100,3.16 [2.41-4.14],9.054241418564907e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,40826,102,7.73 [4.17-14.31],8.131416024149176e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,41253,104,2.27 [1.15-4.50],0.0185623197318636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,35543,95,1.74 [1.37-2.21],5.734139500062591e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34067,87,1.96 [1.57-2.45],2.626261404419575e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40826,102,1.78 [1.10-2.90],0.0199627868642243
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,41521,106,1.55 [1.12-2.15],0.0082678934208698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,41020,104,0.51 [0.31-0.83],0.00693460031748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,40089,100,1.35 [1.03-1.76],0.0277513060708967
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,41331,103,3.38 [1.97-5.77],8.83630542256761e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,40064,101,0.58 [0.40-0.84],0.0037568268543127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,40720,102,2.21 [1.14-4.29],0.0189340261777446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,40089,100,0.68 [0.57-0.81],1.2372253651275198e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,35608,95,2.46 [1.47-4.15],0.000675437159926
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,35512,93,1.79 [1.48-2.17],1.4431364138931512e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,34815,89,1.77 [1.32-2.38],0.0001225192509275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,35624,95,0.64 [0.47-0.86],0.0035417429780543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,41027,103,1.53 [1.12-2.09],0.0077709068337146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,35624,95,1.38 [1.10-1.74],0.0062967260539741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,41382,103,1.91 [1.12-3.26],0.0170856201663429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",35680,94,1.68 [1.17-2.41],0.0050872721197467
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,34914,93,0.44 [0.27-0.73],0.0013327488958853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,40064,101,2.29 [1.78-2.95],1.5319623528746227e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,34584,91,0.60 [0.37-0.98],0.0415773997373764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,40830,102,9.21 [6.79-12.50],4.0386551346265976e-46
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",40826,102,1.34 [1.03-1.75],0.0284227551142475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,41488,104,2.67 [1.91-3.73],8.776376744378221e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,40294,103,1.38 [1.20-1.59],9.908314980978495e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",34555,92,0.59 [0.36-0.95],0.0314114558126171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,41027,103,3.01 [2.02-4.48],6.207594098195725e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,41272,103,0.64 [0.50-0.81],0.0002037899939056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,41393,103,1.31 [1.01-1.69],0.0421344510538552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,35523,94,1.66 [1.12-2.47],0.0115092893809883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,35608,95,2.26 [1.89-2.72],1.7547636262632486e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,34914,93,2.43 [1.17-5.04],0.0174953649611403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,35608,95,1.34 [1.05-1.72],0.0200288402863986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,35538,95,1.46 [1.11-1.93],0.0072953037072027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",35624,95,3.10 [1.67-5.75],0.0003186553747181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",40845,102,2.19 [1.45-3.33],0.0002224110868456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",40974,103,3.18 [2.03-4.96],3.815792938487606e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,34361,89,0.49 [0.28-0.86],0.0131709382126587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,40064,101,1.89 [1.51-2.36],1.9214966574945536e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,40163,102,1.37 [1.11-1.69],0.0030080590374281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35624,95,2.34 [1.99-2.74],2.120865951862516e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41393,103,1.63 [1.14-2.34],0.0073797665697141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,34584,91,0.68 [0.47-0.99],0.0467306052126466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,41521,106,3.45 [1.66-7.17],0.0009094909676572
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,40846,102,3.56 [2.18-5.81],4.0377791769625044e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,41521,106,1.80 [1.04-3.09],0.0344938405962248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,41521,106,26.36 [19.48-35.67],7.841323045594391e-100
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,40826,102,11.68 [5.09-26.79],6.6178830705591945e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34680,94,3.86 [2.85-5.24],3.310688212780851e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,35523,94,2.22 [1.26-3.91],0.0059920186341087
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,41181,102,3.27 [2.02-5.31],1.6466656598125751e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,40974,103,2.68 [2.22-3.23],1.4256555094215388e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,41027,103,5.10 [2.62-9.96],1.7748350212444355e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,41451,105,1.43 [1.08-1.90],0.013973993715247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,40508,102,1.51 [1.04-2.18],0.0285281606887009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,41521,106,1.83 [1.20-2.79],0.0051203916322041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,40826,102,4.79 [4.19-5.47],4.616319057193699e-118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,41020,104,1.81 [1.10-2.96],0.0190876955343361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,40284,100,1.49 [1.30-1.70],5.172282336499535e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,41181,102,2.62 [1.88-3.64],1.0479400529245513e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,40826,102,1.93 [1.59-2.33],1.2800233997936056e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,41488,104,2.53 [1.88-3.41],9.000932253274944e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,40284,100,3.25 [2.33-4.52],2.6344304990095704e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,34646,90,1.84 [1.28-2.63],0.000954219500766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,40284,100,3.28 [2.05-5.24],6.827925152717e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,41488,104,2.59 [2.10-3.19],9.157218136208617e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,40457,102,1.46 [1.05-2.01],0.0231111582618552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,40843,101,1.47 [1.03-2.11],0.0332682454395631
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,41170,103,4.73 [3.23-6.92],1.309019029194442e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,40461,102,0.86 [0.76-0.97],0.0116084065813474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,40961,102,2.68 [1.37-5.24],0.0039298719230431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,34646,90,0.48 [0.27-0.86],0.013110182267856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,40734,104,4.64 [3.72-5.78],3.5657380167700057e-42
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,35512,93,1.93 [1.49-2.48],4.561449495527759e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,40284,100,0.83 [0.72-0.96],0.0122275909203621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,40974,103,4.27 [3.32-5.50],2.4485066335030857e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,40284,100,0.82 [0.71-0.96],0.0123803703438089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,40974,103,0.43 [0.31-0.60],4.450387095017431e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,40777,102,1.66 [1.00-2.76],0.0498471643109975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,40974,103,0.51 [0.38-0.67],3.2991172102025208e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,40007,100,1.68 [1.39-2.03],9.03909286728931e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,35512,93,1.52 [1.08-2.12],0.0157176046756142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,39988,101,2.14 [1.84-2.49],2.3478704613110865e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",34729,89,2.97 [2.25-3.93],1.6316016084991102e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,34646,90,5.12 [1.69-15.50],0.0038274157499939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40294,103,1.55 [1.33-1.79],6.893669883439345e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,41027,103,2.33 [1.19-4.57],0.0133660611624146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,40974,103,0.54 [0.36-0.79],0.0016114622000751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,34646,90,3.66 [2.28-5.87],7.165432002908782e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,40784,105,1.94 [1.12-3.36],0.0180903272250592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,35680,94,2.03 [1.30-3.18],0.0018529654892604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41170,103,1.93 [1.21-3.06],0.005447668422709
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",34729,89,0.63 [0.44-0.91],0.01293641073388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,41382,103,2.16 [1.18-3.94],0.0120361607172693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,40284,100,1.46 [1.17-1.83],0.0009093119095249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40826,102,2.07 [1.36-3.15],0.000676763439499
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,34584,91,0.55 [0.33-0.93],0.0246525431633116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,34720,90,0.59 [0.39-0.90],0.0151278022701078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,34929,92,2.26 [1.91-2.67],2.861590852272529e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,40064,101,1.73 [1.07-2.82],0.0261257367597212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,35608,95,2.12 [1.41-3.18],0.000279350031238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,34555,92,1.33 [1.12-1.59],0.0013810682077107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35512,93,1.43 [1.15-1.78],0.0011827074912099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,40089,100,1.44 [1.16-1.79],0.0008952176129735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,41111,103,0.45 [0.25-0.81],0.0078787754952159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,34584,91,1.78 [1.31-2.43],0.0002231515407221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,41008,105,0.50 [0.32-0.78],0.0023096252790085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,41393,103,1.33 [1.04-1.70],0.0235197475508815
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,34010,89,0.52 [0.30-0.90],0.020291732757185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,41488,104,2.56 [1.69-3.88],1.0196904097613478e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,34646,90,1.45 [1.08-1.95],0.014833835909664
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,35608,95,1.86 [1.37-2.52],6.170114272761152e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,40950,104,1.55 [1.18-2.05],0.0019047926996043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,41488,104,1.54 [1.07-2.21],0.0206724958601344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,41133,105,6.36 [3.79-10.68],2.437471310409696e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,40826,102,2.80 [2.28-3.45],2.40805369112145e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40982,102,2.22 [1.60-3.07],1.5200993913910254e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,41181,102,0.57 [0.34-0.99],0.0444792020721265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,41488,104,0.79 [0.64-0.98],0.034379831166419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,40644,102,2.52 [1.66-3.83],1.396031018383118e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,35674,93,0.65 [0.48-0.89],0.0068786637101748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,41331,103,0.71 [0.50-0.99],0.0440951314040004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,35624,95,1.59 [1.14-2.22],0.0061846155197261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEP,Leptin,41020,104,0.70 [0.54-0.89],0.0039627378842142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,35728,94,1.73 [1.03-2.89],0.0365385423397548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,40995,102,3.14 [1.94-5.08],3.315056457087687e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41043,102,1.34 [1.02-1.76],0.0359706627626583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41521,106,10.58 [6.22-17.97],2.795853584059172e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41323,105,3.16 [1.87-5.33],1.5836801949130833e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40284,100,2.39 [1.67-3.42],2.159449337864239e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,35453,94,1.50 [1.21-1.85],0.000188929918143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,35608,95,3.05 [1.91-4.87],2.883889094442417e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,34584,91,0.61 [0.41-0.91],0.0143574752179077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,34555,92,1.58 [1.24-2.01],0.0001777737775907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,35728,94,3.98 [2.21-7.19],4.550987730754636e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,41020,104,1.70 [1.07-2.69],0.0240273846580039
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,40826,102,1.71 [1.26-2.32],0.0005654017295412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,35523,94,6.32 [4.10-9.75],6.713283071708976e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,40089,100,0.57 [0.38-0.85],0.0062501572959033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,40974,103,5.76 [4.36-7.60],5.350891873137634e-35
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,40974,103,3.06 [2.63-3.57],3.4575514192029926e-47
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,35512,93,1.65 [1.19-2.29],0.0025599043658666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,41521,106,2.04 [1.22-3.44],0.0069446311842633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,40089,100,1.45 [1.14-1.85],0.0025559646171606
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,40788,102,2.29 [1.33-3.93],0.002655881114901
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,35512,93,1.43 [1.01-2.03],0.0460377703382576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,40974,103,5.30 [3.24-8.67],3.2486601765396694e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,40572,102,28.44 [21.04-38.44],3.9775944796746935e-105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,40720,102,0.38 [0.22-0.63],0.0002382577738251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,40089,100,1.73 [1.53-1.94],2.012253859128192e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,40064,101,0.54 [0.33-0.86],0.0099982660855307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,40806,105,1.93 [1.22-3.06],0.0048978120449128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,40089,100,1.50 [1.24-1.81],2.093807415460797e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40579,102,1.90 [1.63-2.21],1.5381932097635042e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,40089,100,1.54 [1.13-2.08],0.0055748908616621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,35674,93,1.77 [1.03-3.03],0.0377371005035689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34729,89,10.60 [5.04-22.29],4.800048808682332e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,35608,95,2.73 [2.21-3.38],9.278902524494682e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,34427,89,1.81 [1.40-2.33],4.7598424766418e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,41020,104,4.43 [2.36-8.32],3.81183522843546e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,40651,102,0.53 [0.31-0.91],0.0206625154372425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,41170,103,1.80 [1.10-2.94],0.0187771135552256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,41488,104,2.16 [1.11-4.21],0.0233407966596223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,40284,100,1.89 [1.38-2.59],7.374598615677932e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,35020,92,1.42 [1.01-1.99],0.0428186803384121
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,35608,95,2.94 [2.21-3.91],1.1375539170895668e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,34427,89,1.59 [1.06-2.40],0.0254326435979131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,40294,103,1.26 [1.01-1.56],0.0369053902601556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,35700,95,2.40 [1.26-4.58],0.0078902409773753
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,34646,90,1.30 [1.05-1.60],0.0163628341346142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35624,95,1.67 [1.38-2.03],2.2604028548509014e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,34427,89,0.53 [0.29-0.97],0.0404790983743054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,34729,89,1.43 [1.05-1.94],0.0226243387315212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,41114,102,0.60 [0.42-0.85],0.0046016836331246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,35512,93,1.77 [1.38-2.25],5.134649500862701e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,34664,89,1.98 [1.45-2.71],2.0199898950289283e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,34914,93,6.02 [2.88-12.59],1.8237015741183409e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,35457,94,1.66 [1.00-2.75],0.0498765550633745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,40284,100,2.03 [1.81-2.27],4.6959252365137265e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35523,94,1.92 [1.12-3.28],0.0175869225819161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,34646,90,1.58 [1.00-2.51],0.0487895198704077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,40966,104,2.11 [1.25-3.57],0.0053602483612216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,41133,105,0.57 [0.38-0.85],0.0061474840964825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40974,103,1.28 [1.07-1.52],0.0056146372990862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,34555,92,1.64 [1.26-2.13],0.0001998114629306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,40089,100,3.11 [2.53-3.83],3.811535056893583e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,34555,92,1.53 [1.25-1.88],5.108860624671013e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,35608,95,2.49 [1.46-4.26],0.0007979879310712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,34065,88,3.99 [2.05-7.77],4.8034855033260375e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,34584,91,0.55 [0.31-0.98],0.0413363672290597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40720,102,1.82 [1.65-2.02],2.108734548497929e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,34555,92,0.77 [0.60-0.99],0.0408854532019199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",40064,101,1.62 [1.30-2.01],1.273536288548213e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,41521,106,33.45 [17.38-64.37],7.95044603737717e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,35079,89,2.69 [1.82-3.96],6.073828159585229e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,41020,104,2.03 [1.28-3.20],0.0024044066367181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,40089,100,0.71 [0.52-0.97],0.0306214222003371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,35680,94,0.49 [0.28-0.88],0.0175582311729743
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,41020,104,4.83 [2.93-7.96],6.30524632863716e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,41027,103,2.33 [1.39-3.90],0.001300560423367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,35608,95,1.74 [1.16-2.62],0.007864306701922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,35624,95,1.96 [1.37-2.80],0.0002145911724108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,35523,94,1.38 [1.05-1.81],0.0215586389518014
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,40826,102,3.79 [2.48-5.79],7.10562489097354e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,35599,94,2.67 [1.07-6.63],0.0344534105793858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,34584,91,0.49 [0.28-0.85],0.0106611429060469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,34729,89,1.48 [1.01-2.18],0.0447631824186116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,35608,95,1.62 [1.02-2.58],0.0389933172794178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,41027,103,0.46 [0.24-0.86],0.0159631294276998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,40974,103,1.86 [1.70-2.04],1.107790045021219e-38
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35523,94,1.81 [1.12-2.93],0.0154470829776541
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,34840,93,1.50 [1.03-2.19],0.0347463790478668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,41020,104,2.01 [1.28-3.14],0.0022992321700445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,35523,94,5.95 [3.85-9.18],8.080914507012562e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,41329,103,4.12 [3.49-4.88],9.412012335252954e-62
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,40826,102,1.70 [1.00-2.89],0.048278888840104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,41521,106,0.73 [0.58-0.92],0.0067585329189574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,41181,102,0.74 [0.60-0.89],0.0021360835108718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,41027,103,1.35 [1.01-1.80],0.0439006390074017
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40760,102,1.43 [1.15-1.77],0.0010613484923203
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,34914,93,1.65 [1.03-2.65],0.0375838132552809
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35624,95,1.37 [1.08-1.73],0.0089222533800804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40974,103,2.64 [2.16-3.22],2.744280643881177e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41027,103,3.75 [2.37-5.92],1.5694855045246822e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,41053,102,1.32 [1.03-1.69],0.027754522861258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,35020,92,0.75 [0.56-1.00],0.0473814799127197
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,41133,105,2.90 [1.61-5.22],0.0003784821427265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,41027,103,1.54 [1.00-2.37],0.0494101238722909
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,40725,100,2.04 [1.10-3.78],0.023101312439077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,35608,95,1.33 [1.02-1.75],0.0382520248113469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,41337,106,2.57 [1.34-4.93],0.0045999400858567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,34720,90,2.09 [1.74-2.52],9.5151972199108e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,34584,91,1.95 [1.53-2.48],6.384013743652928e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40284,100,0.73 [0.59-0.90],0.0031633064055607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,34646,90,1.68 [1.23-2.29],0.0010719409783018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40826,102,2.75 [2.29-3.29],6.094101287991132e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,35680,94,0.38 [0.22-0.65],0.0004052440614784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,35458,93,0.71 [0.56-0.89],0.0032194243837395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,40089,100,1.91 [1.69-2.16],5.105765826717676e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,41270,104,1.74 [1.06-2.85],0.0274450479423567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,35680,94,0.49 [0.34-0.71],0.0001709045471603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,40089,100,1.94 [1.55-2.42],5.121097569888052e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,35728,94,0.37 [0.18-0.77],0.0081768133791879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,34729,89,3.29 [2.11-5.12],1.47928948807835e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,35348,90,1.89 [1.06-3.37],0.0300001472009317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,40974,103,1.90 [1.69-2.15],4.245864040997869e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,40533,102,1.67 [1.05-2.67],0.0304577186678983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,40974,103,1.49 [1.08-2.06],0.0142939130005673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,34646,90,1.49 [1.12-1.99],0.0065347096514996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,40974,103,0.75 [0.62-0.90],0.0023309259323085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,40089,100,0.70 [0.50-0.99],0.0426964548086301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,40714,102,3.04 [2.05-4.51],3.080514790051431e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,40064,101,0.56 [0.37-0.85],0.0069788332079943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40720,102,1.57 [1.29-1.92],6.779306506584318e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,35674,93,0.47 [0.24-0.93],0.0301864744265872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,35680,94,14.58 [10.40-20.43],1.2882538679829278e-54
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,35523,94,1.60 [1.11-2.32],0.0123482857391005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40580,102,1.80 [1.08-3.02],0.0244744874806717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,41521,106,4.64 [2.41-8.91],4.259929036627869e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,39880,100,1.63 [1.24-2.13],0.0003821807572454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,40974,103,1.92 [1.26-2.94],0.0025842011019586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,35002,91,1.38 [1.03-1.85],0.0333920895192123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,40284,100,0.59 [0.44-0.79],0.0004297014884065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,40284,100,1.46 [1.12-1.91],0.0054587466574838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,35512,93,1.87 [1.52-2.30],2.281268204174369e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,40089,100,1.80 [1.57-2.06],1.0501386508120149e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,35624,95,1.68 [1.15-2.44],0.0070671458525711
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,40061,102,1.73 [1.25-2.39],0.0010122456233833
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,34555,92,1.88 [1.52-2.32],4.36501620851861e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,40826,102,1.58 [1.19-2.10],0.0015053922813961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,35512,93,1.42 [1.09-1.86],0.0094254895937365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,40294,103,1.39 [1.06-1.82],0.0177630213726764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,34646,90,0.56 [0.33-0.96],0.0358572248692601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,41027,103,3.72 [2.32-5.96],4.48965776303848e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",34555,92,0.55 [0.31-0.97],0.0397390169145614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,41382,103,2.18 [1.19-3.98],0.0114431741402607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,34914,93,1.54 [1.07-2.20],0.0186636478001854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,34555,92,0.61 [0.40-0.93],0.0219162973742306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,35434,91,2.04 [1.55-2.70],4.786718564890325e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,41334,104,3.06 [1.99-4.70],3.363714016018e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,34729,89,2.81 [1.89-4.19],3.590774116726308e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,34646,90,1.72 [1.24-2.37],0.0010173573992013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,41054,102,4.27 [2.40-7.61],8.310029177990859e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41020,104,6.77 [4.11-11.16],6.48940602362094e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,34646,90,1.65 [1.04-2.62],0.0321087232713217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,34729,89,2.67 [2.21-3.23],6.559886608467569e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,40089,100,1.57 [1.28-1.93],1.7467698031629396e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,40089,100,1.42 [1.10-1.83],0.0074766945562935
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,41393,103,1.71 [1.12-2.62],0.0137808391802412
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,34646,90,1.84 [1.18-2.86],0.0070977022011088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,35512,93,1.40 [1.08-1.82],0.0100047091362898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,35624,95,2.16 [1.61-2.90],2.4775253691692885e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,34555,92,2.36 [2.05-2.71],3.7247173071249792e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,40826,102,1.50 [1.23-1.82],5.081594260638228e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,39945,99,2.26 [1.40-3.64],0.0007772711646444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,41382,103,2.38 [1.35-4.19],0.0027485678813406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,41272,103,1.56 [1.10-2.20],0.0117015471712899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,34729,89,1.26 [1.05-1.51],0.0109727247402102
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,40974,103,1.38 [1.04-1.83],0.0235914149065554
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,41020,104,1.59 [1.07-2.38],0.0222566933932815
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,41020,104,0.63 [0.51-0.78],2.202870300825136e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,34914,93,4.25 [3.68-4.90],5.709897035075591e-88
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,35728,94,10.06 [7.50-13.48],9.269396713906935e-54
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,40974,103,2.13 [1.14-3.96],0.0173311705825969
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,34914,93,2.27 [1.61-3.20],3.134734418176892e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,40826,102,1.64 [1.07-2.51],0.0224069046863719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,41382,103,2.24 [1.25-4.02],0.0070150076268772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,41393,106,7.67 [6.41-9.18],2.0812052568451372e-109
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,35535,95,2.23 [1.44-3.45],0.0003275983059443
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,40826,102,2.79 [1.97-3.94],6.509001923169719e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,40617,102,0.68 [0.53-0.87],0.0020972083641429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,41488,104,1.58 [1.34-1.87],1.0295319889585173e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,41521,106,0.74 [0.58-0.94],0.0158448506458378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,35674,93,0.63 [0.45-0.86],0.0045218822606667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,40590,101,3.17 [2.15-4.68],5.3271469825667195e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,40587,102,0.55 [0.36-0.86],0.0081078750986344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,40089,100,1.47 [1.07-2.01],0.0175131897621217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,34427,89,0.77 [0.62-0.94],0.0125828182055241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,35680,94,2.42 [1.48-3.97],0.0004411150959477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,41181,102,2.45 [1.72-3.51],8.568002695023731e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,40974,103,10.60 [8.66-12.96],1.6842502654485411e-116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,41027,103,1.55 [1.25-1.92],5.907591657802535e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,41393,103,6.18 [5.03-7.59],2.142187306349973e-67
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,34729,89,3.08 [2.06-4.61],4.048756178173697e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,34646,90,1.31 [1.12-1.53],0.0005287133757117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",40064,101,0.57 [0.38-0.87],0.0083687577042097
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,40284,100,2.25 [1.67-3.03],9.876122404825496e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,40089,100,5.18 [4.43-6.05],9.147039570156188e-96
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,40089,100,2.51 [1.88-3.34],3.3635706926226325e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,35512,93,0.54 [0.31-0.92],0.0234055623034829
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,35680,94,1.54 [1.05-2.26],0.0278578740711586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,41393,103,2.17 [1.44-3.28],0.0002277383355023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,35523,94,2.13 [1.91-2.38],4.6087354213245414e-42
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,41393,103,1.82 [1.11-2.99],0.0172677837649904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35512,93,0.68 [0.47-0.99],0.0415904179732367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,35624,95,1.41 [1.02-1.93],0.0359703534430787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,34555,92,1.69 [1.42-2.00],1.591712912708078e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,40089,100,1.91 [1.18-3.10],0.0089395373918124
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35624,95,1.75 [1.10-2.78],0.0189673534793635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,41133,105,0.79 [0.63-0.99],0.0430776419236851
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,35674,93,2.36 [1.39-4.04],0.0016093916492516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,41027,103,0.55 [0.32-0.93],0.0271494392168393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,40896,102,4.92 [3.36-7.20],2.568849498554329e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,35523,94,0.88 [0.78-0.99],0.0350434457069149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,40720,102,0.38 [0.19-0.76],0.0058461631642194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,34427,89,1.37 [1.09-1.73],0.0069147739919632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",34584,91,2.72 [2.09-3.53],6.481247980775182e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,40826,102,2.64 [2.24-3.11],2.8565621267111203e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,40974,103,1.37 [1.14-1.64],0.0006949978956512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40826,102,1.69 [1.26-2.28],0.0005202654543587
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,34646,90,1.38 [1.08-1.78],0.0109290419150114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,41382,103,2.40 [2.05-2.81],1.0680116101659971e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,40972,103,4.24 [2.08-8.66],7.155772580721841e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,34584,91,0.59 [0.39-0.87],0.0087664328520422
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,34646,90,2.44 [1.65-3.61],7.686922979722589e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,35523,94,1.85 [1.25-2.74],0.0021568759140279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,35523,94,2.76 [2.37-3.22],8.604059492955685e-38
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,35020,92,0.43 [0.26-0.72],0.0012390421194307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,35608,95,2.14 [1.69-2.70],1.9393583851153006e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,40658,102,2.90 [2.59-3.25],1.7387356742979262e-74
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,41451,105,1.74 [1.06-2.85],0.0279020587753196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,35674,93,2.48 [1.99-3.08],3.706436379368485e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,35512,93,1.71 [1.47-1.98],1.9492881479946095e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,41133,105,2.71 [1.27-5.76],0.0096820082710513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,35728,94,0.40 [0.16-0.98],0.0459395720122115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,41007,105,1.42 [1.04-1.94],0.0266207534237325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,41183,103,2.15 [1.44-3.20],0.0001634587636783
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,40974,103,1.54 [1.09-2.17],0.013603259392603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,41133,105,1.94 [1.23-3.06],0.0042633536327448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,40957,103,1.32 [1.05-1.66],0.0158714583559445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,35700,95,4.34 [2.36-7.98],2.261285305045893e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,34362,89,1.23 [1.03-1.47],0.0240294937423306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,41020,104,3.20 [2.39-4.29],7.345072834026585e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,40834,104,2.40 [1.54-3.73],0.0001089996379251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,41382,103,2.63 [1.49-4.65],0.0008748500395712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,41521,106,2.42 [1.38-4.22],0.0019548460017393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39988,101,1.99 [1.53-2.58],2.336469712783109e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35020,92,1.84 [1.49-2.26],9.836063115851732e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41170,103,2.88 [2.03-4.08],2.523709893737433e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,41027,103,0.52 [0.33-0.84],0.0068289163841596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,40896,104,2.91 [1.36-6.22],0.0057940619145354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",35020,92,1.50 [1.09-2.08],0.0131654373419247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,34646,90,2.82 [1.58-5.06],0.0004787605403276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,34555,92,0.31 [0.14-0.69],0.0041484294867747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,34584,91,0.63 [0.44-0.91],0.0143935198942705
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,40826,102,0.80 [0.65-0.97],0.0254128931335504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,41027,103,1.50 [1.20-1.88],0.0003488881418751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,41170,103,1.56 [1.10-2.21],0.0122253486372892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,40228,103,1.94 [1.59-2.36],5.5804423239393525e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40720,102,2.91 [2.29-3.70],2.926895983343607e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40720,102,1.56 [1.35-1.79],1.0864915912479946e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41488,104,1.55 [1.02-2.37],0.0423345087213017
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41133,105,1.59 [1.00-2.51],0.0497640547382456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41054,102,3.13 [2.56-3.84],1.874468340580644e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40284,100,4.50 [3.96-5.11],7.850606868124709e-118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41054,102,2.30 [1.38-3.82],0.0013876344891979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,34914,93,4.72 [3.09-7.21],6.528694791826166e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41393,103,2.12 [1.32-3.40],0.0019050757129293
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41027,103,2.75 [1.71-4.45],3.438868235450628e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41027,103,1.95 [1.62-2.35],1.3516367607780905e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41382,103,2.37 [1.31-4.29],0.0044045597391816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41415,104,5.80 [4.33-7.79],1.0483117841238502e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40720,102,1.40 [1.06-1.84],0.0169386923263036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41382,103,2.76 [2.12-3.59],3.9659652534104894e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40720,102,5.77 [5.12-6.51],3.325546784236715e-179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,41488,104,0.54 [0.29-0.99],0.0474549511016495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,41181,102,0.67 [0.47-0.97],0.0312309462890887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41451,106,0.38 [0.27-0.55],1.3208499326419385e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,35680,94,3.71 [2.66-5.18],1.1293987047699548e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,35608,95,1.45 [1.18-1.78],0.0003343754634505
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,34646,90,1.74 [1.41-2.15],2.251193909485865e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,34729,89,1.41 [1.06-1.87],0.0192181123792052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,40089,100,2.20 [1.76-2.75],3.1380823282555398e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,34646,90,1.83 [1.50-2.24],4.2343836409559024e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,35674,93,4.47 [2.34-8.52],5.64115083221388e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,34555,92,1.81 [1.54-2.13],4.19818512495685e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",34646,90,1.86 [1.40-2.47],2.2284770170591025e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,40982,102,1.61 [1.18-2.19],0.0029561479835605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,41027,103,8.88 [6.61-11.93],1.4468804305188775e-47
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,34950,92,1.32 [1.01-1.73],0.0436197461781477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,34555,92,0.58 [0.35-0.95],0.0317932161340507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,34584,91,0.74 [0.56-0.98],0.0376408149436027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,35338,92,0.37 [0.17-0.79],0.0101515041114617
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,40720,102,1.29 [1.06-1.58],0.0125141170963787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,40826,102,1.69 [1.02-2.80],0.0402049728289831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,40720,102,2.31 [1.56-3.43],2.976249493824568e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,35608,95,2.78 [2.31-3.34],2.5229090504061118e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,41111,103,6.04 [3.73-9.78],2.697884074947799e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,34646,90,0.37 [0.19-0.75],0.0053437065257514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,41133,105,0.62 [0.46-0.84],0.0022098128696181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,40972,103,1.88 [1.27-2.77],0.001576843700111
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,41521,106,1.39 [1.10-1.74],0.004837414400496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",41027,103,2.02 [1.30-3.13],0.0016924484196646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,35512,93,3.19 [2.76-3.69],4.7944007936006745e-55
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,38924,100,1.94 [1.32-2.84],0.0007144522628172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40590,101,1.83 [1.23-2.74],0.0031355458208918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,41393,103,1.58 [1.27-1.97],4.519496716661101e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,40064,101,1.51 [1.01-2.27],0.044548928455478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,35608,95,2.35 [1.34-4.11],0.0028207996484892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,35512,93,2.64 [1.80-3.87],6.952978157892552e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,34646,90,2.59 [2.10-3.19],5.021034102681463e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,40294,103,2.43 [2.08-2.84],6.646177362571314e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,34555,92,1.32 [1.03-1.68],0.0270544756667297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,35608,95,3.05 [2.67-3.49],3.4631792896948014e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,35523,94,1.58 [1.24-2.03],0.000270370003964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,34584,91,0.74 [0.56-0.99],0.0413066267901016
